登录

TS Imaging Closes ¥10M Pre-A Funding Round

作者: Mailman 2020-09-07 17:06
清影华康
http://www.tsimaging.net/
企业数据由 动脉橙 提供支持
高分辨磁共振血管壁成像解决方案提供商 | 战略融资 | 运营中
中国-北京
2022-10-17
一脉阳光
查看

According to VCBeat, Beijing Qingying Huakang Technology Co., Ltd ("TS Imaging"), a leading company focusing on high-resolution magnetic resonance angiography (MRA), recently announced the completion of a Pre-A funding round of tens of millions. The latest round was led by BOHE Angel Fund, with participation from TusStar. Proceeds from this round will be used to promote the research and development of products and further expand sales channels.


In 2016, TS Imaging was jointly established by Tsinghua University and relevant experts in the industry to transform the scientific research achievements of the Biomedical Imaging Research Center of Tsinghua University into products to provide high-resolution magnetic resonance imaging (MRI) of vessel wall for patients with cerebrovascular diseases. The team from Tsinghua University has nearly 30-year experience in technology development, pathological verification, clinical trials and data analysis, making TS Imaging a leader in this field of high-resolution MRI.


Since its establishment, TS Imaging has been marked as one of the Beijing High-tech Enterprises and Zhongguancun High-tech enterprises, and obtained a number of invention and utility model patents. At present, the products of TS Imaging have been sold to more than 100 domestic hospitals with advantages in cerebrovascular disease, helping to promote the R&D and clinical services of those hospitals.


TS Imaging integrates high-resolution MRI, imaging sequences, special imaging coil with high signal-to-noise ratio, AI-based interpretation and workstation imaging to form a comprehensive solution. It provides for hospitals the one-stop accurate imaging solution from imaging to reporting, so that the application of high-resolution MRI can be more simple and fast clinically.


>>>>

About BOHE Angel Fund


Founded in 2015, BOHE Angel Fund is a venture capital firm with AUM of RMB 200 million. The company focuses on investing in technology-based enterprises engaged in medical and healthcare in the early stage.


>>>>

About TusStar 


Founded in 1999 and headquartered in Beijing, China, TusStar is an investment firm that integrates innovation services and building business platforms. The company has incubated over 5000 firms, among which are excellent companies, including 49 Diamond Companies, 45 Golden Seed Project companies, and 34 listed companies as well as great entrepreneurs.

相关赛道 医学影像
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

Shukun Technology Bags ¥200M in New Round of Financing

DEEP INFORMATICS++ Closes ¥100M Series B Funding Round

KFBIO Closes on Series B Funding Round

Yizhun Intelligent Closes on ¥100 million Series B Funding Round

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Shukun Technology Bags ¥200M in New Round of Financing

2020-09-07
下一篇

专访北极光创投宋高广:基因治疗打开无限想象空间,三大难点仍待突破【投资人说】

2020-09-08